News & Updates

FRESCO-2: Fruquintinib improves OS in heavily pretreated mCRC

30 Nov 2022 by

Fruquintinib, a highly selective and potent oral tyrosine kinase inhibitor of VEGFR*-1, -2, and -3, significantly improves overall survival (OS) in heavily pretreated patients with metastatic colorectal cancer (mCRC), according to the FRESCO-2** trial presented at ESMO 2022.

FRESCO-2: Fruquintinib improves OS in heavily pretreated mCRC

30 Nov 2022

Intermittent fasting may not be healthy after all

29 Nov 2022 by

Currently in vogue, intermittent fasting (IF) – which switches between periods of eating and fasting – may not be as beneficial as many have thought.

Intermittent fasting may not be healthy after all

29 Nov 2022

LSM improves prediction of cholangitis outcomes

28 Nov 2022

Liver stiffness measurement (LSM) by vibration-controlled transient elastography (VCTE) is independently associated with primary biliary cholangitis (PBC) outcomes, a study has shown.

LSM improves prediction of cholangitis outcomes

28 Nov 2022

COVID-19 reinfection doubles the risk of death

26 Nov 2022 by

COVID-19 reinfection doubles the risk of death and triples the risk of hospitalization, with post-acute sequelae in the pulmonary and extra-pulmonary organ systems, in a new study.

COVID-19 reinfection doubles the risk of death

26 Nov 2022

Berberine ursodeoxycholate safe, effective in primary sclerosing cholangitis

22 Nov 2022

Treatment with HTD1801, an ionic salt of berberine and ursodeoxycholic acid with pleiotropic mechanisms of action, appears to substantially improve outcomes in patients with primary sclerosing cholangitis (PSC), according to a study.

Berberine ursodeoxycholate safe, effective in primary sclerosing cholangitis

22 Nov 2022

Inflammatory bowel disease may cause psoriasis, psoriatic arthritis

22 Nov 2022

Inflammatory bowel disease appears to be a causal risk factor for both psoriasis and psoriatic arthritis, with Crohn’s disease specifically associated with the development of the two psoriasis outcomes, according to a study.

Inflammatory bowel disease may cause psoriasis, psoriatic arthritis

22 Nov 2022

Delayed EoE diagnosis persists since disease description

21 Nov 2022

To this day, diagnostic delay (DD) remains a problem since the first description of eosinophilic esophagitis (EoE) nearly 30 years ago, reveals a study. Notably, one-third of EoE patients suffer a persistently high DD of at least 10 years.

Delayed EoE diagnosis persists since disease description

21 Nov 2022

Frailty tied to worse outcomes after surgery for colonic volvulus

21 Nov 2022 by

In patients who had undergone nonelective resection for colonic volvulus, frailty appears to worsen clinical outcomes, according to a recent study. Screening for frailty could help improve risk stratification and guide healthcare decision making.